Cargando…
Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle
BACKGROUND: Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phas...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636827/ https://www.ncbi.nlm.nih.gov/pubmed/37946266 http://dx.doi.org/10.1186/s42523-023-00274-4 |
_version_ | 1785133273963298816 |
---|---|
author | Vasco, Karla A. Carbonell, Samantha Sloup, Rebekah E. Bowcutt, Bailey Colwell, Rita R. Graubics, Karlis Erskine, Ronald Norby, Bo Ruegg, Pamela L. Zhang, Lixin Manning, Shannon D. |
author_facet | Vasco, Karla A. Carbonell, Samantha Sloup, Rebekah E. Bowcutt, Bailey Colwell, Rita R. Graubics, Karlis Erskine, Ronald Norby, Bo Ruegg, Pamela L. Zhang, Lixin Manning, Shannon D. |
author_sort | Vasco, Karla A. |
collection | PubMed |
description | BACKGROUND: Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phase for dry-cow therapy: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal grab samples were collected before and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing. RESULTS: Overall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiota abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most commonly possessed ESBL genes followed by members of Enterobacteriaceae. CONCLUSION: This study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks. Fecal shedding of ESBL-producing Enterobacteriaceae, which was classified as a serious public health threat, varied across animals. Together, these findings highlight the need for additional studies aimed at identifying factors associated with shedding levels and the dissemination and persistence of antibiotic resistance determinants on dairy farms across geographic locations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42523-023-00274-4. |
format | Online Article Text |
id | pubmed-10636827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106368272023-11-11 Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle Vasco, Karla A. Carbonell, Samantha Sloup, Rebekah E. Bowcutt, Bailey Colwell, Rita R. Graubics, Karlis Erskine, Ronald Norby, Bo Ruegg, Pamela L. Zhang, Lixin Manning, Shannon D. Anim Microbiome Research BACKGROUND: Intramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phase for dry-cow therapy: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal grab samples were collected before and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing. RESULTS: Overall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiota abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most commonly possessed ESBL genes followed by members of Enterobacteriaceae. CONCLUSION: This study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks. Fecal shedding of ESBL-producing Enterobacteriaceae, which was classified as a serious public health threat, varied across animals. Together, these findings highlight the need for additional studies aimed at identifying factors associated with shedding levels and the dissemination and persistence of antibiotic resistance determinants on dairy farms across geographic locations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42523-023-00274-4. BioMed Central 2023-11-09 /pmc/articles/PMC10636827/ /pubmed/37946266 http://dx.doi.org/10.1186/s42523-023-00274-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Vasco, Karla A. Carbonell, Samantha Sloup, Rebekah E. Bowcutt, Bailey Colwell, Rita R. Graubics, Karlis Erskine, Ronald Norby, Bo Ruegg, Pamela L. Zhang, Lixin Manning, Shannon D. Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title | Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title_full | Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title_fullStr | Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title_full_unstemmed | Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title_short | Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
title_sort | persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636827/ https://www.ncbi.nlm.nih.gov/pubmed/37946266 http://dx.doi.org/10.1186/s42523-023-00274-4 |
work_keys_str_mv | AT vascokarlaa persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT carbonellsamantha persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT slouprebekahe persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT bowcuttbailey persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT colwellritar persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT graubicskarlis persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT erskineronald persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT norbybo persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT rueggpamelal persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT zhanglixin persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle AT manningshannond persistenteffectsofintramammaryceftiofurtreatmentonthegutmicrobiomeandantibioticresistanceindairycattle |